Smith & Nephew (LON:SN) Insider Angie Risley Purchases 373 Shares

Smith & Nephew plc (LON:SN) insider Angie Risley acquired 373 shares of Smith & Nephew stock in a transaction that occurred on Friday, August 22nd. The shares were purchased at an average cost of GBX 1,382 per share, for a total transaction of £5,154.86.

Smith & Nephew Price Performance

Smith & Nephew stock opened at GBX 1,383 on Wednesday. The business’s fifty day moving average price is GBX 1,191.94 and its 200 day moving average price is GBX 1,108.17. The company has a market cap of £15.16 billion, a price-to-earnings ratio of 49.79, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62. The company has a quick ratio of 0.84, a current ratio of 2.51 and a debt-to-equity ratio of 70.22.

Wall Street Analysts Forecast Growth

Several brokerages have commented on SN. Deutsche Bank Aktiengesellschaft raised their target price on shares of Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the stock a “hold” rating in a report on Wednesday, August 6th. Berenberg Bank raised their target price on shares of Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the stock a “hold” rating in a report on Thursday, August 7th. Finally, JPMorgan Chase & Co. raised their target price on shares of Smith & Nephew from GBX 1,357 to GBX 1,438 and gave the stock an “overweight” rating in a report on Wednesday, August 6th. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of GBX 1,379.33.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.